A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
14 02 2019
Historique:
received: 21 02 2018
revised: 04 05 2018
accepted: 24 09 2018
pubmed: 26 10 2018
medline: 12 9 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

The present study aimed to disentangle the risk of the three major transportation noise sources-road, railway, and aircraft traffic-and the air pollutants NO2 and PM2.5 on myocardial infarction (MI) mortality in Switzerland based on high quality/fine resolution exposure modelling. We modelled long-term exposure to outdoor road traffic, railway, and aircraft noise levels, as well as NO2 and PM2.5 concentration for each address of the 4.40 million adults (>30 years) in the Swiss National Cohort (SNC). We investigated the association between transportation noise/air pollution exposure and death due to MI during the follow-up period 2000-08, by adjusting noise [Lden(Road), Lden(Railway), and Lden(Air)] estimates for NO2 and/or PM2.5 and vice versa by multipollutant Cox regression models considering potential confounders. Adjusting noise risk estimates of MI for NO2 and/or PM2.5 did not change the hazard ratios (HRs) per 10 dB increase in road traffic (without air pollution: 1.032, 95% CI: 1.014-1.051, adjusted for NO2 and PM2.5: 1.034, 95% CI: 1.014-1.055), railway traffic (1.020, 95% CI: 1.007-1.033 vs. 1.020, 95% CI: 1.007-1.033), and aircraft traffic noise (1.025, 95% CI: 1.006-1.045 vs. 1.025, 95% CI: 1.005-1.046). Conversely, noise adjusted HRs for air pollutants were lower than corresponding estimates without noise adjustment. Hazard ratio per 10 μg/m³ increase with and without noise adjustment were 1.024 (1.005-1.043) vs. 0.990 (0.965-1.016) for NO2 and 1.054 (1.013-1.093) vs. 1.019 (0.971-1.071) for PM2.5. Our study suggests that transportation noise is associated with MI mortality, independent from air pollution. Air pollution studies not adequately adjusting for transportation noise exposure may overestimate the cardiovascular disease burden of air pollution.

Identifiants

pubmed: 30357335
pii: 5144026
doi: 10.1093/eurheartj/ehy650
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-603

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

Harris Héritier (H)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Danielle Vienneau (D)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Maria Foraster (M)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.
ISGlobal, Universitat Pompeu Fabra (UFP), Barcelona Biomedical Research Park (PRBB), Doctor Aiguader, 88, 08003 Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP); Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, Spain.

Ikenna C Eze (IC)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Emmanuel Schaffner (E)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Kees de Hoogh (K)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Laurie Thiesse (L)

Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Wilhelm Klein-Strasse 27, Basel, Switzerland.
Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Birmannsgasse 8, Basel, Switzerland.

Franziska Rudzik (F)

Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Wilhelm Klein-Strasse 27, Basel, Switzerland.
Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Birmannsgasse 8, Basel, Switzerland.

Manuel Habermacher (M)

n-sphere AG, Räffelstrasse 29, Zürich, Switzerland.

Micha Köpfli (M)

n-sphere AG, Räffelstrasse 29, Zürich, Switzerland.

Reto Pieren (R)

Empa, Laboratory for Acoustics/Noise control, Swiss Federal Laboratories for Materials Science and Technology, Überlandstrase 129, Dübendorf, Switzerland.

Mark Brink (M)

Federal Office for the Environment, Division of Noise and Non-Ionizing Radiation, Bern, Switzerland.

Christian Cajochen (C)

Centre for Chronobiology, Psychiatric Hospital of the University of Basel, Wilhelm Klein-Strasse 27, Basel, Switzerland.
Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, Birmannsgasse 8, Basel, Switzerland.

Jean Marc Wunderli (JM)

Empa, Laboratory for Acoustics/Noise control, Swiss Federal Laboratories for Materials Science and Technology, Überlandstrase 129, Dübendorf, Switzerland.

Nicole Probst-Hensch (N)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Martin Röösli (M)

Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, Basel, Switzerland.
University of Basel, Petersplatz 1, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH